Login to Your Account



U.S. Patent Disclosures


Friday, September 28, 2012
• Clarus Therapeutics Inc., of Northbrook, Ill., was issued U.S. Patent No. 8,241,664, "Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same," related to its testosterone product, CLR-610.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription